| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Financial Officer | SVP, Finance
3 companies
Quimi Daphne is a Chief Financial Officer at AMICUS THERAPEUTICS, INC. with holdings across 3 companies. Recent SEC Form 4 filings include 3 buys and 9 sells.
Estimated insider holdings value: $5.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 12, 2024 | IPSC Century Therapeutics, Inc. | Director | Buy | 5,000 | $1.53 | $7,657.00 | New | -12.3% | -67.5% | |
| May 15, 2024 | AMLX Amylyx Pharmaceuticals, Inc. | Director | Buy | 5,000 | $1.89 | $9,436.03 | +181.8% | +9.3% | +148.4% | |
| Jan 18, 2023 | FOLD Amicus Therapeutics, Inc. | Chief Financial Officer | Sell | 11,923 | $12.79 | $152,443.50 | -1.5% | -9.2% | -5.2% | |
| Sep 1, 2022 | FOLD Amicus Therapeutics, Inc. | Chief Financial Officer | Sell | 4,397 | $11.29 | $49,620.58 | -1.3% | +4.7% | +11.8% | |
| Aug 5, 2022 | FOLD Amicus Therapeutics, Inc. | Chief Financial Officer | Sell | 5,798 | $12.00 | $69,576.00 | -1.7% | -17.1% | +7.9% | |
| Jun 17, 2022 | FOLD Amicus Therapeutics, Inc. | Chief Financial Officer | Sell | 4,396 | $9.00 | $39,564.00 | -1.3% | +17.1% | +40.0% | |
| Dec 21, 2020 | FOLD Amicus Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 5,000 | $24.09 | $120,473.50 | -2.0% | - | - | |
| Oct 1, 2020 | FOLD Amicus Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 5,000 | $14.02 | $70,099.00 | -2.4% | - | - | |
| Jul 1, 2020 | FOLD Amicus Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 6,872 | $15.47 | $106,325.65 | -3.2% | - | - | |
| Jan 9, 2020 | FOLD Amicus Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 15,000 | $9.93 | $148,951.50 | -8.2% | - | - |